Rocket Pharmaceuticals to Present at TD Cowen and Leerink Partners Healthcare Conferences
Rocket Pharmaceuticals, Inc. RCKT | 3.55 | -1.93% |
MNSN HOLDINGS INC MNSH | 54.00 | 0.00% |
Rocket Pharmaceuticals, Inc. (https://rocketpharma.com/) said CEO Gaurav Shah will join a fireside chat and the company will hold investor meetings at the TD Cowen 46th Annual Health Care Conference on March 2, 2026 (11:10 a.m. ET), and at the Leerink Partners Global Healthcare Conference on March 10, 2026 (9:20 a.m. ET). Webcasts will be available on the company’s investor events page at https://ir.rocketpharma.com/events-presentations (also linked via https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fir.rocketpharma.com%2Fevents-presentations&esheet=54429668&newsitemid=20260223001849&lan=en-US&anchor=here&index=2&md5=78cc8f9dceba6ce10a8c412f9aa9e56f).
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rocket Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202602230700BIZWIRE_USPR_____20260223_BW001849) on February 23, 2026, and is solely responsible for the information contained therein.
